SIMULTANEOUS DETERMINATION OF KETOPROFEN ENANTIOMERS AND PROBENECID IN PLASMA AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY

被引:23
作者
PALYLYK, EL [1 ]
JAMALI, F [1 ]
机构
[1] UNIV ALBERTA,FAC PHARM & PHARMACEUT SCI,EDMONTON T6G 2N8,ALBERTA,CANADA
来源
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS | 1991年 / 568卷 / 01期
基金
英国医学研究理事会;
关键词
D O I
10.1016/0378-4347(91)80352-D
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A rapid, sensitive, stereospecific reversed-phase high-performance liquid chromatographic method was developed for simultaneous quantitation of ketoprofen enantiomers, probenecid and their conjugates in biological fluids. Following addition of the internal standard, indoprofen, the constituents were extracted into isooctane-isopropanol (95.5), water-washed, extracted with chloroform, then evaporated and the residue sequentially derivatized with ethyl chloroformate and L-leucinamide hydrochloride. The formed diastereomers were chromatographed on a reversed-phase column with a mobile phase of 0.06 M KH2PO4-acetonitrile-triethylamine (65:35:0.1) at a flow-rate of 1 ml/min and a detection wavelength of 275 nm. The minimum quantifiable concentration was 0.5-mu-g/ml in 100-mu-l of rat plasma and urine samples. The intra- and inter-day coefficients of variation for this method are < 10%. The assay is successfully applied to a pharmacokinetic study. The simultaneous analysis of probenecid with several other non-steroidal anti-inflammatory drugs was also successful.
引用
收藏
页码:187 / 196
页数:10
相关论文
共 29 条
[1]  
BABER N, 1978, CLIN PHARMACOL THER, V24, P298
[2]   DETERMINATION OF THE ENANTIOMERS OF INDOPROFEN IN BLOOD-PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AFTER RAPID DERIVATIZATION BY MEANS OF ETHYL CHLOROFORMATE [J].
BJORKMAN, S .
JOURNAL OF CHROMATOGRAPHY, 1985, 339 (02) :339-346
[3]   DETERMINATION OF THE ENANTIOMERS OF KETOPROFEN IN BLOOD-PLASMA BY ION-PAIR EXTRACTION AND HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY OF LEUCINAMIDE DERIVATIVES [J].
BJORKMAN, S .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1987, 414 (02) :465-471
[4]  
BROCKS D, IN PRESS J PHARM SCI
[5]   THE METABOLIC CHIRAL INVERSION AND DISPOSITIONAL ENANTIOSELECTIVITY OF THE 2-ARYLPROPIONIC ACIDS AND THEIR BIOLOGICAL CONSEQUENCES [J].
CALDWELL, J ;
HUTT, AJ ;
FOURNELGIGLEUX, S .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (01) :105-114
[6]   CLINICAL PHARMACOKINETICS OF PROBENECID [J].
CUNNINGHAM, RF ;
ISRAILI, ZH ;
DAYTON, PG .
CLINICAL PHARMACOKINETICS, 1981, 6 (02) :135-151
[7]   DOSE-DEPENDENT PHARMACOKINETICS OF PROBENECID IN THE RAT [J].
EMANUELSSON, BM ;
PAALZOW, LK .
BIOPHARMACEUTICS & DRUG DISPOSITION, 1988, 9 (01) :59-70
[8]   HEPATIC AND RENAL CLEARANCES OF PROBENECID IN THE RAT [J].
EMANUELSSON, BM ;
PAALZOW, LK .
PHARMACOLOGY, 1989, 38 (01) :61-68
[10]  
FOSTER RT, 1988, DRUG METAB DISPOS, V16, P623